PharmaEngine, Inc. (TPEX:4162)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
63.00
-0.70 (-1.10%)
Aug 6, 2026, 11:25 AM CST

PharmaEngine Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
422.55387.641,751274.65318.78426.03
Depreciation & Amortization
10.4410.059.319.028.6110.26
Loss (Gain) From Sale of Investments
----5.53-45.46-0.83
Stock-Based Compensation
0.230.41.33.382.370.09
Provision & Write-off of Bad Debts
0.010.020-00.01-0.22
Other Operating Activities
-267.15-276.88344.77-33.31-54.79-81.69
Change in Accounts Receivable
-3.11,582-1,670-13.830.13541.22
Change in Inventory
-8.39-11.5-12.4818.47-28.9419.31
Change in Accounts Payable
-35.58---2.058.62
Change in Other Net Operating Assets
23.88-0.2732.894.123.366.87
Operating Cash Flow
178.471,727456.73256.97202.01929.67
Operating Cash Flow Growth
-91.82%278.09%77.74%27.21%-78.27%1335.36%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.28-0.28-0.81-0.41-3.44-0.23
Sale (Purchase) of Intangibles
---0.6--0.5-
Investment in Securities
-991.81-266.18-114.67-854.48-183.98-105
Other Investing Activities
-0.05-0.190.55-0.59-0.2-1.77
Investing Cash Flow
-992.14-266.66-115.54-855.48-188.12-107

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--8.45-7.67-7.54-8-9.6
Net Debt Issued (Repaid)
-8.67-8.45-7.67-7.54-8-9.6
Repurchase of Common Stock
------133.41
Common Dividends Paid
-861.92-861.92-215.44-287.19-387.71-363.99
Financing Cash Flow
-870.6-870.37-223.11-294.73-395.71-507

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
------0.75
Net Cash Flow
-1,684589.83118.08-893.24-381.81314.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
178.191,727455.92256.56198.57929.44
Free Cash Flow Growth
-91.83%278.70%77.71%29.20%-78.64%1335.01%
Free Cash Flow Margin
18.49%189.44%18.07%33.42%30.34%141.94%
Free Cash Flow Per Share
1.2411.993.171.781.386.42
Levered Free Cash Flow
55.821,617-19.65159.87105.29723.9
Unlevered Free Cash Flow
56.021,617-19.54160.06105.34724.04

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.320.140.180.310.080.21
Cash Income Tax Paid
390.77396.2861.3792.35124.42200.65
Change in Working Capital
12.391,606-1,6508.76-27.51576.02